Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis

Ocular Immunology and Inflammation

Volumn 19, Issue 1, 2011, Pages 84-85

  Kurz, Paul A ^a,b   Chheda, Lena V ^a   Kurz, Daryl E ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cataract; difluprednate; ocular hypertension; pars planitis; pharmacotherapy

Indexed keywords

DIFLUPREDNATE; PREDNISOLONE ACETATE; PREDNISONE; TIMOLOL; TRIAMCINOLONE;

ARTICLE; CASE REPORT; CATARACT EXTRACTION; CHILD; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; INSOMNIA; INTERMEDIATE UVEITIS; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POSTERIOR SUBCAPSULAR CATARACT; SCHOOL CHILD; SUBCAPSULAR CATARACT; TREATMENT REFUSAL; VISUAL ACUITY; VITRECTOMY; WEIGHT GAIN;

ADMINISTRATION, TOPICAL; CATARACT; CHILD; EMULSIONS; FLUPREDNISOLONE; GLUCOCORTICOIDS; HUMANS; MALE; OCULAR HYPERTENSION; PARS PLANITIS; PREDNISONE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME; VISUAL ACUITY; WEIGHT GAIN;

EID: 79952838746     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.512993     Document Type: Article

References (6)

1. Whitcup SM. Intermediate uveitis. In: Nussenblatt RB, Whitcup SM, eds. Uveitis: Fundamentals and Clinical Practice. Philadelphia, PA: Mosby Elsevier; 2010: 269-277.
2. Jamal KN. Callanan DG. The role of difuprednate ophthal-mic emulsion in clinical practice. Clin Ophthalmol. 2009; 3: 381-390.
3. Kornfeld MS, Silverstein, SM, Cooke, DL, Vogel, R, Crockett, RS. Difuprednate ophthalmic emulsion 0.05% for postop-erative infammation and pain. J Cat Refract Surg. 2009; 35:26-34.
4. Tajika T, Shirasaki Y, Kimura M, et al. Ocular distribution and metabolism after instillation of difuprednate ophthal-mic emulsion in rabbits. The 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Poster B744, Program 2654, Fort Lauderdale, FL, USA, 6-10 May 2007.
5. Nakano S, Yamamoto T, Kirii, E, Abe S, Yamashita H. Steroid eye drop treatment (difuprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2010; 248:805-810.
6. Plitz-Seymour, J. Uhler, TA. Other secondary glaucomas. In: Shaarawy TM, Sherwood, MB, Hitchings, RA, Crowston, JG, eds. Glaucoma: Medical Diagnosis and Therapy, Vol. 1. Printed in China: Saunders Elsevier; 2009: 419-430.